Works matching IS 14783223 AND DT 2020 AND VI 40 AND IP 10


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials.

    Published in:
    Liver International, 2020, v. 40, n. 10, p. 2476, doi. 10.1111/liv.14587
    By:
    • Díaz‐González, Álvaro;
    • Sapena, Víctor;
    • Boix, Loreto;
    • Brunet, Mercè;
    • Torres, Ferrán;
    • LLarch, Neus;
    • Samper, Esther;
    • Millán, Olga;
    • Corominas, Josep;
    • Iserte, Gemma;
    • Sanduzzi‐Zamparelli, Marco;
    • da Fonseca, Leonardo G.;
    • Darnell, Anna;
    • Belmonte, Ernest;
    • Forner, Alejandro;
    • Ayuso, Carmen;
    • Bruix, Jordi;
    • Reig, María
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Mechanisms for increased risk of diabetes in chronic liver diseases.

    Published in:
    Liver International, 2020, v. 40, n. 10, p. 2489, doi. 10.1111/liv.14556
    By:
    • Svegliati‐Baroni, Gianluca;
    • Gaggini, Melania;
    • Carli, Fabrizia;
    • Barbieri, Chiara;
    • Cucco, Monica;
    • Youne, Ramy;
    • Rosso, Chiara;
    • Bugianesi, Elisabetta;
    • Gastaldelli, Amalia
    Publication type:
    Article
    21
    22
    23

    Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies.

    Published in:
    Liver International, 2020, v. 40, n. 10, p. 2385, doi. 10.1111/liv.14535
    By:
    • Yao, Betty B.;
    • Fredrick, Linda M.;
    • Schnell, Gretja;
    • Kowdley, Kris V.;
    • Kwo, Paul Y.;
    • Poordad, Fred;
    • Nguyen, Kinh;
    • Lee, Samuel S.;
    • George, Christophe;
    • Wong, Florence;
    • Gane, Edward;
    • Abergel, Armand;
    • Spearman, Catherine W.;
    • Nguyen, Tuan;
    • Hung Le, Manh;
    • Pham, Thuy TT.;
    • Mensa, Federico;
    • Asselah, Tarik;
    • Dore, Gregory
    Publication type:
    Article
    24

    Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.

    Published in:
    Liver International, 2020, v. 40, n. 10, p. 2553, doi. 10.1111/liv.14519
    By:
    • Rey, Esther;
    • Meléndez‐Rodríguez, Florinda;
    • Marañón, Patricia;
    • Gil‐Valle, Miriam;
    • Carrasco, Almudena G.;
    • Torres‐Capelli, Mar;
    • Chávez, Stephania;
    • Pozo‐Maroto, Elvira;
    • Rodríguez de Cía, Javier;
    • Aragonés, Julián;
    • García‐Monzón, Carmelo;
    • González‐Rodríguez, Águeda
    Publication type:
    Article
    25
    26
    27
    28
    29

    Issue Information.

    Published in:
    Liver International, 2020, v. 40, n. 10, p. 2311, doi. 10.1111/liv.14149
    Publication type:
    Article